CELLGENTECH
CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. We are now performing the translational clinical research for LCAT deficiency as the 1st target and trying to expand this new therapy to other rare diseases.
CELLGENTECH
Industry:
Biotechnology Therapeutics
Founded:
2003-10-20
Address:
Chiba, Chiba, Japan
Country:
Japan
Website Url:
http://www.cellgentech.com
Total Employee:
11+
Status:
Active
Contact:
043-441-4121
Email Addresses:
[email protected]
Total Funding:
3.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Euro Pound Sterling Japanese Yen
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Minutia
Biotech, Therapeutics
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nissay Capital
Nissay Capital investment in Venture Round - CellGenTech
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Venture Round - CellGenTech
Nissui Pharmaceutical
Nissui Pharmaceutical investment in Corporate Round - CellGenTech
Official Site Inspections
http://www.cellgentech.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.22 K
- Host name: www.gmoserver.jp
- IP address: 160.251.229.82
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "CellGenTech"
CellGenTech, Inc.
CellGenTech Inc. signed a joint development and license agreement with Kyorin Pharmaceutical Co., Ltd. for GMAC of Fabry disease. June 17, 2022. Toho Holdings Co., Ltd. announced that …See details»
CellGenTech - Crunchbase Company Profile & Funding
CellGenTech is a Therapeutics Company. CellGenTech is currently exploring opportunities for alliances to advance the development of gene/cell therapy using Pre-Adipocytes Technology. …See details»
会社概要｜セルジェンテック株式会社 - cellgentech.com
CellGenTech., Inc: 設立年月日: 2003年10月20日: 本社 〒260-0856 千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ208 アクセス Contact [email protected]: ラボ …See details»
CellGenTech 2025 Company Profile: Valuation, Funding
CellGenTech General Information Description. Developer of a bio-venture company designed to provide therapeutic products. The company is developing processed cellular therapy …See details»
CellGenTech, Inc. - VentureRadar
Jun 3, 2024 " CellGenTech, Inc. is a pioneering biopharmaceutical company specializing in ex-vivo gene therapy platforms using Genetically Modified Adipocytes (GMAC). The company's …See details»
CellGenTech - Products, Competitors, Financials, Employees ...
CellGenTech is a biotechnology company focused on the development of gene therapies and regenerative medicine. The company specializes in the research and development of medical …See details»
CellGenTech - Funding, Financials, Valuation & Investors
CellGenTech is a Therapeutics Company. How much funding has this organization raised over time? ShowSee details»
CellGenTech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Aug 25, 2023 Explore CellGenTech, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 9 literature, Disease Domain:Hemic and Lymphatic ...See details»
CellGenTech - Company Profile - Tracxn
Feb 8, 2025 CellGenTech's latest funding round was on Mar 19, 2019. View complete company profile of CellGenTech. Our Lite Plan Awaits you - Its Free! Sign up now to unlock full access …See details»
Cellgentech - Craft
Cellgentech (셀젠텍) is a company that develops BIT convergence products for the pharmaceutical sector. Its products include FOBI, a device that can image and analyze …See details»
CellGenTech - Contacts, Employees, Board Members, Advisors
CellGenTech has 4 current employee profiles, including Corporate Auditor Shiga Akira. CellGenTech has 3 board members and advisors, including Tanio Masami . ContactsSee details»
お知らせ｜セルジェンテック株式会社 - cellgentech.com
CellGenTech, Inc. 〒260-0856 千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ101. 043-441-4121.See details»
セルジェンテック株式会社への追加出資について – ZACROS
当社は、成長領域である細胞培養受託事業の拡大を加速するため、バイオベンチャー「セルジェンテック株式会社」への投資契約を5月9日付で締結、5月10日付で3億円を追加出資いた …See details»
バイオベンチャー ダイレクトリー セルジェンテック株式会社
企業情報 代表者氏名： 代表取締役社長 麻生 雅是. 設立年月日： 2003年10月20日. 資本金： 439 百万円See details»
共同研究・共同開発に向けて｜セルジェンテック株式会社
CellGenTech, Inc. 〒260-0856 千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ101. 043-441-4121.See details»
CellGenTech, Inc. (CellGenTech, Inc.) - 药物管线_专利_临床试验_投 …
了解CellGenTech, Inc. (CellGenTech, Inc.)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验和9篇文献，疾病领域:血液及淋巴系统疾病，内分泌与代谢疾病，神经系统疾病，技 …See details»
加工ヒト脂肪細胞医薬品による再生医療分野研究開発 [セルジェ …
セルジェンテック株式会社は脂肪細胞の長い寿命を活かし、疾病治療タンパク質を遺伝子土入し、それを産生する加工ヒト脂肪細胞を患者さんへ移植し、治療に必要な酵素やタンパク質を …See details»
Federal government announces support for cutting-edge, AI- and …
22 hours ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for …See details»
創薬シーズ｜セルジェンテック株式会社 - cellgentech.com
CellGenTech, Inc. 〒260-0856 千葉県千葉市中央区亥鼻1-8-15 千葉大亥鼻イノベーションプラザ101. 043-441-4121.See details»
Seeds | CellGenTech, Inc.
Cellgentech, Inc. will conduct the step-wise development of "transduced adipocyte-based medicine" as the gene therapy making use of adipocytes, from the following point of view. …See details»